Vitreofoveal Traction Associated With Pilocarpine for Presbyopia
Vitreofoveal Traction Associated With Pilocarpine for Presbyopia
About this item
Full title
Author / Creator
Publisher
Thorofare: Slack, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Thorofare: Slack, Inc
Subjects
More information
Scope and Contents
Contents
Vuity (pilocarpine HCL ophthalmic 1.25%) was approved for the treatment of presbyopia in October 2021. Previous case series have reported the presence of vitreofoveal traction and retinal detachment following pilocarpine administration, but this was not reported in the recent randomized control trials assessing the efficacy of Vuity. The authors re...
Alternative Titles
Full title
Vitreofoveal Traction Associated With Pilocarpine for Presbyopia
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2692755939
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2692755939
Other Identifiers
ISSN
2325-8160
E-ISSN
2325-8179
DOI
10.3928/23258160-20220629-01
